These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12402660)

  • 1. Anaplastic large cell lymphoma and acquired angioedema: a novel association?
    Rossi D; Gaidano G
    Ann Ital Med Int; 2002; 17(3):143-5. PubMed ID: 12402660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angioedema: first manifestation of non-Hodgkin's lymphoma].
    Foti R; Fazio P; Lizzio G; Leonardi R
    Ann Ital Med Int; 2002; 17(3):185-8. PubMed ID: 12402667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired C1-inhibitor deficiency.
    Frank M
    Behring Inst Mitt; 1989 Jul; (84):161-4. PubMed ID: 2679531
    [No Abstract]   [Full Text] [Related]  

  • 4. Angioedema presenting as chronic gastrointestinal symptoms.
    Eck SL; Morse JH; Janssen DA; Emerson SG; Markovitz DM
    Am J Gastroenterol; 1993 Mar; 88(3):436-9. PubMed ID: 8438855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disease and acquired C1 inhibitor deficiency.
    Castelli R; Deliliers DL; Zingale LC; Pogliani EM; Cicardi M
    Haematologica; 2007 May; 92(5):716-8. PubMed ID: 17488706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
    Cugno M; Castelli R; Cicardi M
    Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of a t(2;5)-associated novel chimeric protein p80 and its clinicopathological significance in anaplastic large cell lymphoma].
    Shioda M; Mori S
    Rinsho Ketsueki; 1996 May; 37(5):422-5. PubMed ID: 8691588
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes.
    Bain BJ; Catovsky D; Ewan PW
    Cancer; 1993 Dec; 72(11):3318-22. PubMed ID: 8242559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C1 inhibitor deficiency. Heredity and acquired forms. Symptoms, diagnostic and therapeutic problems].
    Obtułowicz K; Kapusta M; Obtułowicz A; Mazurkiewicz A
    Przegl Lek; 2002; 59(6):438-41. PubMed ID: 12418282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B and T lymphocytes in the blood].
    Hokland P; Heron I
    Ugeskr Laeger; 1979 May; 141(20):1311-4. PubMed ID: 313115
    [No Abstract]   [Full Text] [Related]  

  • 13. The chronic proliferative disease of large granular lymphocytes.
    Bassan R; Rambaldi A; Barbui T
    Haematologica; 1989; 74(1):85-94. PubMed ID: 2498190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.
    Rodig SJ; Shahsafaei A; Li B; Mackay CR; Dorfman DM
    Hum Pathol; 2005 Oct; 36(10):1113-9. PubMed ID: 16226112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
    Wang HY; Bossler AD; Schaffer A; Tomczak E; DiPatri D; Frank DM; Nowell PC; Bagg A
    Cancer Genet Cytogenet; 2007 Jan; 172(1):45-53. PubMed ID: 17175379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY; Zhao Y; Anderson WF; Johnston PB
    Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t(14;19)(q32;q13) incidence and significance in B-cell lymphoproliferative disorders.
    Kelly RJ; Wright D; Patil K; Chapple M; Jalihal SS; Barrans SL; O'Connor SJ; Turner K; Jack AS; Owen RG
    Br J Haematol; 2008 May; 141(4):561-3. PubMed ID: 18373708
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukaemic expression of anaplastic large cell lymphoma with 46,XX,ins(2;5)(p23;q15q35) in a child with dihydropyrimidine dehydrogenase deficiency.
    van den Berg H; Noorduyn A; van Kuilenburg AB; Kroes W; de Jong D
    Leukemia; 2000 Apr; 14(4):769-70. PubMed ID: 10764168
    [No Abstract]   [Full Text] [Related]  

  • 19. The pathobiology of lymphocyte transformation.
    Taylor CR
    Pathobiol Annu; 1982; 12():65-84. PubMed ID: 6761633
    [No Abstract]   [Full Text] [Related]  

  • 20. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.